These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 29309104)

  • 21. High prevalence of advanced colorectal neoplasia in the Thai population: a prospective screening colonoscopy of 1,404 cases.
    Siripongpreeda B; Mahidol C; Dusitanond N; Sriprayoon T; Muyphuag B; Sricharunrat T; Teerayatanakul N; Chaiwong W; Worasawate W; Sattayarungsee P; Sangthongdee J; Prarom J; Sornsamdang G; Soonklang K; Wittayasak K; Auewarakul CU
    BMC Gastroenterol; 2016 Aug; 16(1):101. PubMed ID: 27553627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
    Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E
    Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Participation, yield, and interval carcinomas in three rounds of biennial FIT-based colorectal cancer screening.
    Stegeman I; van Doorn SC; Mundt MW; Mallant-Hent RC; Bongers E; Elferink MA; Fockens P; Stroobants AK; Bossuyt PM; Dekker E
    Cancer Epidemiol; 2015 Jun; 39(3):388-93. PubMed ID: 25910865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of the immunochemical fecal test (FIT) for detection of advanced adenomas in colorectal carcinoma screening in an asymptomatic population.
    Miuţescu B; Sporea I; Popescu A; Bota S; Iovănescu D; Burlea A; Mos L; Palaghia M; Vasilescu A; Miuţescu E
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):302-7. PubMed ID: 24340508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels.
    Toes-Zoutendijk E; van Leerdam ME; Dekker E; van Hees F; Penning C; Nagtegaal I; van der Meulen MP; van Vuuren AJ; Kuipers EJ; Bonfrer JMG; Biermann K; Thomeer MGJ; van Veldhuizen H; Kroep S; van Ballegooijen M; Meijer GA; de Koning HJ; Spaander MCW; Lansdorp-Vogelaar I;
    Gastroenterology; 2017 Mar; 152(4):767-775.e2. PubMed ID: 27890769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colorectal cancer screening in the Czech Republic.
    Zavoral M
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S29-30. PubMed ID: 18368637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Data quality and colonoscopy performance indicators in the prevalent round of a FIT-based colorectal cancer screening program.
    Lund M; Erichsen R; Valori R; Møller Jensen T; Helle Njor S; Laurberg S; Andersen B;
    Scand J Gastroenterol; 2019 Apr; 54(4):471-477. PubMed ID: 30978128
    [No Abstract]   [Full Text] [Related]  

  • 28. Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial.
    You JJ; Liu Y; Kirby J; Vora P; Moayyedi P
    Trials; 2015 Jul; 16():296. PubMed ID: 26156248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative study of two rounds of colorectal cancer screening in 80, 000 targeted population in Haining].
    Jiang CX; Wang XP; Shen YZ
    Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):707-711. PubMed ID: 28926902
    [No Abstract]   [Full Text] [Related]  

  • 30. Participation rates for organized colorectal cancer screening programmes: an international comparison.
    Klabunde C; Blom J; Bulliard JL; Garcia M; Hagoel L; Mai V; Patnick J; Rozjabek H; Senore C; Törnberg S
    J Med Screen; 2015 Sep; 22(3):119-26. PubMed ID: 25967088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests.
    Logan RF; Patnick J; Nickerson C; Coleman L; Rutter MD; von Wagner C;
    Gut; 2012 Oct; 61(10):1439-46. PubMed ID: 22156981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colorectal cancer screening in LHU4 Chiavarese, Italy: ethical, methodological and outcome evaluations at the end of the first round.
    Ferrari Bravo M; De Conca V; Devoto GL; Sironi M; Mele R; Fumagalli A; Rimassa P; Rossi G; Zampogna A; Sticchi C; Gabutti G;
    J Prev Med Hyg; 2012 Mar; 53(1):37-43. PubMed ID: 22803318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [An analysis of results of the elderly colorectal cancer screening study].
    Zhang C; Fang Y; Hong Z; Jiang Q; Li W; Li J
    Zhonghua Nei Ke Za Zhi; 2014 Sep; 53(9):715-8. PubMed ID: 25511405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implementation of population screening for colorectal cancer by repeated fecal occult blood test in the Netherlands.
    Denters MJ; Deutekom M; Fockens P; Bossuyt PM; Dekker E
    BMC Gastroenterol; 2009 Apr; 9():28. PubMed ID: 19393087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluating colorectal cancer screening strategies (immunological test vs biochemical test) in Catalonia, Spain 2008-2010].
    García Martínez M; Binefa Rodríguez G; Milà Díaz N; Rodríguez Moranta F; Gonzalo Diego N; Muñoz Sánchez C; Espinàs Piñol JA; Borràs Andrés JM; Moreno Aguado V
    Rev Esp Salud Publica; 2011 Dec; 85(6):593-602. PubMed ID: 22249590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of a nationwide screening colonoscopy program for colorectal cancer.
    Pox CP; Altenhofen L; Brenner H; Theilmeier A; Von Stillfried D; Schmiegel W
    Gastroenterology; 2012 Jun; 142(7):1460-7.e2. PubMed ID: 22446606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early detection of colorectal cancer with faecal occult blood test screening.
    Paimela H; Malila N; Palva T; Hakulinen T; Vertio H; Järvinen H
    Br J Surg; 2010 Oct; 97(10):1567-71. PubMed ID: 20603855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
    Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colorectal cancer screening in a low-incidence area: general invitation versus family risk targeting: a comparative study from Montenegro.
    Panic N; Rösch T; Smolovic B; Radunovic M; Bulajic M; Pavlovic-Markovic A; Krivokapic Z; Djuranovic S; Ille T; Bulajic M
    Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1222-5. PubMed ID: 26067224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.